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Abstract: Easy access to chloroquine (CQ) in many developing countries can result to in-
take of inappropriate doses. This study was therefore conducted to evaluate the acute ef-
fects of high doses of CQ on hematological parameters and plasma Na+and K+ concen-
trations. To do this, Swiss albino rats were administered incremental doses of CQ in-
traperitoneally at dose rates ranging between 0.5 to 8mg/kg b.wt. Two hours later, blood
samples were taken and analysed. 8mg/kg b.wt of CQ induced significant decrease in red
blood cells (RBC), hemoglobin (Hb) and significant increase in mean corpuscular volume
(MCV). There was a significant increase in white blood cell count at all dose levels. Packed
cell volume (PCV), mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin
concentration (MCHC) were not affected by all dose ranges. There was significant increase
in plasma Na+ and K+ by dose rates of 4 and 8 mg/kg but not by lower doses. These data
indicate that most CQ induced toxicities on the formed elements of blood occurs at doses
greater than 4 times the standard therapeutic dose in rats.
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INTRODUCTION
Malaria infection can be characterised by leucopoenia, lymphopaenia and thrombopaenia
(Nicolas et al, 1997) as well as the digestion of host erythrocytes' hemoglobin by parasites
(Sherman, 1979, Slater, 1992, and Roth, 1989). Chloroquine is one of the most widely used
drugs for the treatment of malaria (Yayon et al, 1984, Ndyomugyenyi and Magnussen 1997).
However, several toxic effects of CQ have been reported including neutrophilic toxicity
(Naisbitt, et al, 1997), myo and neurotoxicities (Estes, et al, 1987, Ochsendorf & Runne 1991)
and retinopathy (Ochsendorf & Runne 1991). Data regarding CQ toxicty on blood cells which
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habours the plasmodium parasites are scanty. The need to evaluate the possibility of toxicity
of CQ on parasite-free cells is therefore vital. This will establish whether in addition to
parasitic effects, CQ induces deleterious effects of its own. Pharmacokinetically, CQ is rapidly
absorbed following parenteral injections, and widely distributed in body tissues (Aderomu et
al, 1986, Krishna and White 1996) and so toxicity can be rapid. High concentrations are
obtained in red blood cells (Salako & Adeluis 1983). Uncontrolled use of CQ which occurs in
developing countries (Odoi et al, 1995, Ndyomugyenyi & Magnussen, 1997) can be a source
of great danger (Ochsendorf & Runne 1991). This study was therefore conducted to examine
the hematological and plasma Na+ and K+ alterations following acute in vivo exposure of
adult rats to incremental doses of CQ. This is in regard to the fact that the study of drug
effects on cellular constituents of blood has not been a standard part of routine investigations
performed in screeing of drugs for potential toxic effects (Hinderling, 1997).
MATERIALS AND METHODS
A nimals
Thirty five Swiss Albino rats of mixed sex, mean body weight 170±12g and aged 6
months were used in this study. They were purchased from the Department of Veterinary
Physiology and Pharmacology, University of Ibadan. They were housed in cages in a insect-
proof house and provided with commercially prepared rat diet (21% protein, 3.5% fat, 6%
fibre, 0.8% calcium, and 0.8% phosphorus, Ladokun Feeds Nig. Ltd, Ibadan). Animals were
randomly allocated to five experimental groups (1 , 1, H, N and V) of 5 rats each while
group ¥ (n=10 served as control). Care was taken to ensure that all animals were treated in
conformity with the standard animal ethics and experimentation guidelines.
Drug preparation and administration
Chloroquine phosphate was obtained in 5ml ampoules from KRKA, Novo Mesto Yu-
goslavia. Each ml of injectable solution contained 64.5mg chloroquine phosphate (equivalent
to 40mg chloroquine base). The required dose was further diluted with physiological saline
and volume made up to 1ml followed by intraperitoneal injection. Rats in groups I , H, HI,
F and V recieved an incremental dose of 0.5, 1, 2, 4 and 8mg/kg of the CQ base by in-
traperitoneal injection. The dose administered to group IE was calculated from the dose given
to group I (0.5mg/kg) by arithmetically multiplying it by 2. Successive doses were calculated
in similar manner by multiplying the dose administered to the preceding group by 2. Group
ML received equal volume of physiological saline. Rats were returned to their cages.
Blood collection and analyses
Twohours post injection, each rat recieved an intraperitoneal injection of pentobarbital
(Nembutal, 50mg/kg, Abbot laboratories, USA) to induce anaesthesia in order to minise pain
during the experimental procedure. After rats have been be fully anesthetised, blood sample
was collected by cardiac puncture. The collected blood was immediately transferred into
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a sample bottle prepared with ethylene diamine tetracetic acid (EDTA). Determination of
haematological parameters was carried out within 1 hour of blood collection. For electrolyte
analysis, plasma was separated by centrifugation. Fresh plasma was then transferred into
polypropylene tubes and frozen at-70°C untill analysed. Packed cell volume (PCV) hae-
moglobin (Hb), white blood cells (WBC) and red blood cells (RBC) were determined using
standard mathods. Erythrocyte indices were estimated as proposed by Ganong (1995). Serum
Na+ and K+ were determined by flame photometry (Gallenkamp, London).
Statistical analysis
Data are expressed as mean values ± SEM. Statistical inhomogeneity between ex-
perimental and controlled measurements were analysed by ANOVA using the statistical
package StatView 4.5 (Stat View, Abacus Corp, USA 1992-1994).
RESULTS
The data indicate that 8mg/kg CQ produced significant decrease in RBC, Hb, and in-
crease in mean corpuscular volume (MCV) over the control values. All doses ranging between
0.5 and 8mg/kg produced significant increase in WBC counts over the control values. Packed
cell volume (PCV), mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin
concentration (MCHC) were not affected by all dose ranges (Table 1). There was significant
increase in plasma Na+ with drug doses at 4mg/kg and 1.28mg/kg. Doses between 0.5 to
2mg/kg did not induce any significant change in plasma Na+ concentration (Fig. 1). Plasma
K+ was significantly increased by drug doses of ranging between 2 to 8mg/kg but not by
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Table 1. Hematological changes following the administration of increasing doses of
chloroquine.
Test group statistically significant at *P<0.01, **P<0.001 and ***P<0.0001) compared to control.
PCV=packed cell volume, RBC=red blood cells, WBC=white blood cells, Hb=hemoglobin,










Fig. 1. Plasma sodium changes following the.administration of increasing doses of




































Fig. 2. Plasma potassium changes following the administration of increasing doses of




One of the prominent changes noticed following the administration of CQ on hematol-
ogy is the increase in WBC count. Administration of the therapeutic as well as higher doses
resulted in an increase in WBC, even though the increase was not in a strictly dose depen-
dent manner. Because no differential leucocyte count was performed, it was not possible to
determine whether the increase was due to lymphocytes or neutrophils. However, previous
study had shown that polymorphonulear (PMN) leucocytes accumulates CQ more than
mononuclear leucocytes and red blood cells. This was attributed to the acidic cellular or-
ganelles such as lysosomes contained in the PMN Leucocytes which trap the weak base CQ
(Raghoebar et al, 1986), and the accumulation of CQ in leucocytes is both dose and time
dependent (French et al, 1987). The explanation for the increase in WBC count is that since
the increase in WBC was detectable as early as 2 hours after CQ injection, the drug might
have acted on the bone marrow reserve pool to release mature and immature neutrophils.
Although some other reports have shown an increase in leucocyte count following drug ad-
ministration, these chemicals are not structurally related to CQ. The reports attributed such
increase to direct stimulation of the immunological defence system due to the presence of the
drug as a foreign compound in the body.
The result also showed that CQ induced no changes in RBC, Hb and MCV at doses
below 8mg/kg. This mode of response indicate that induction of toxicity occurred in a
dose-dependent manner. A previous study (Agomo et al 1992) found that CQ decreased the
numbers of reticulocytes in normal mice. However, they also observed a decrease in the
numbers of nucleated cells. Although the mechanisms responsible for the decrease in the
RBC counts are not clear, compartmental shifts, hypotension, intravascular haemolysis or
splenic sequestration of cellular blood elements are possible causes. Previous stuides has
shown that ferriprotoporphyrin (FP) K induced RBC hemolysis is potentiated by CQ. The
change in RBC numbers did not affect the PCV because probably this effect was counter-
balanced by the increase in MCV.
Even though the cause of death in one rat receiving 8mg/kg was not investigated, it
was attributed to CQ toxicity. Previous study have shown that CQ can induced potentially
lethal hypotension, especially when given by intravenous injection (Krishna and White 1996).
High doses of CQ can also have some clinical implications since the result of a study in
rats showed evidence that febrile illness can contribute to the potentiation of CQ toxicty
(Osifo, 1980). There was evidence equally that digestion of hemoglobin by malaria parasites
produces FP K which induces RBC hemolysis and its effect is potentiated by CQ. The pos-
sibility exists therefore for an interactive effect with high CQ doses.
6
The absence of marked changes in PCV with increase in the concentration of plasma
electrolyte in response to the high CQ doses may suggest that there was possibly no changes
in fluid balance. Several drugs have been reported to induce inbalance in serum sodium and
potassium (Brunner & Frick 1968, Feig & McCurdy 1977, Lawson, 1981). Some of the
mechanisms suggested for such changes in the absence of fluid shifts is alteration of plasma
membrane integrity which can result to changes in permeability. The significant increase in
plasma Na+ and K+ observed may suggest impaired ability of erythrocytes to maintain ca-
tion gradients through membrane perturbing at these high doses resulting to increased per-
meability of cell membrane.
The overall result indicate that high doses of the CQ can affect cellular composition of
the blood through alteration of blood cell numbers.
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